
Portal vein thrombosis (PVT) frequently affects patients with cirrhosis. However, while in the absence of cirrhosis PVT frequently relies on underlying pro-thrombotic factors (and consequently the need of anticoagulation is obvious), in the context of cirrhosis PVT is considered to be secondary to liver disease, and whether PVT is a cause or a consequence of impaired liver function is controversial.
In contrast with the formal suggestion to treat with anticoagulants PVT in the context of cirrhosis, the issue of the management of PVT remains controversial. Actually, in clinical practice, the decision in most of the cases is not to treat due to the fear for an increased bleeding risk. Additionally, accumulating evidence suggests that spontaneous recanalization of PVT may occur without treatment.
This webinar has the aim of exploring open issues regarding PVT in cirrhosis, in particular about pathophysiology, outcome and management.
Date: 22 March 2022
Time: 3:00pm CET | 10:00am EDT | 10:00pm CST Asia
Webinar ID: 832 5635 4366
Webinar Secretariat: jcm.webinar@mdpi.com
Medicina Interna 1, Azienda di Rilievo Nazionale ad Alta Specializzazione Civico - Di Cristina - Benfratelli, Palermo, Italy;
Physician and clinical researcher, mainly interested in the management of advanced liver diseases, vascular liver diseases, liver transplantation, HCC, liver diseases in thalassemia and iron overload, liver ultrasound.
Actually, Consultant Medical Doctor at the Department of Internal Medicine, ARNAS Civico, Palermo, Italy. Since 2019, Referent the Regional Referral Centre for Rare Diseases, Budd-Chiari syndrome, hereditary hemorrhagic telangiectasia.
Previously working as Consultant of Hepatology and Gastroenterology at the Ca’ Niguarda Hospital (Milan, Italy), of Gastroenterology and Endoscopy at V Cervello Hospital (Palermo, Italy), as well as in other hospitals all over Italy, and as clinical research fellow at the Liver Transplantation Unit and Hepatobiliary Medicine of the Royal Free Hospital, London, UK.
Since 2017, alleged by the Italian Ministry of Education, University and Research to the National Scientific Qualification as Professor of Internal Medicine and of Gastroenterology and Hepatology.
Author of much more the 100 English language published studies (first name in more than half).
Peer-reviewer and Editor of plenty authoritative international Journals, mainly in the field of Hepatology, Gastroenterology, Internal Medicine, Hematology.
On Tuesday, 22 March 2022, MDPI and the Journal of Clinical Medicine organized the 6th Webinar on Clinical Medicine, entitled "New Developments about Portal Vein Thrombosis in Cirrhosis”. This online seminar was chaired by Dr. Andrea Mancuso from Medicina Interna 1, Azienda di Rilievo Nazionale ad Alta Specializzazione Civico - Di Cristina - Benfratelli, Palermo, Italy and had as speakers an international panel of experts: Dr. Andrea Mancuso, Dr. Xingshun Qi, Dr. Ton Lisman, and Dr. Aurelie Plessier.
The first speaker to kick off the webinar was Dr. Andrea Mancuso and he reported controversies in the management of portal vein thrombosis. Dr. Xingshun Qi, from the General Hospital of Northern Theater Command, China, followed with his presentation on the evolution of portal vein thrombosis. Dr. Ton Lisman, from the University Medical Center Groningen, the Netherlands, then presented his research on the pathophysiology of portal vein thrombosis. Finally, Dr. Aurelie Plessier from Hopital Beaujon, France, gave an overview on the prevention and treatment of portal vein thrombosis. Speaker presentations were followed by a Q&A session moderated by the chair.
The webinar was offered via Zoom and required registration to attend. The full recording can be found below. In order to stay updated on the next webinars on Clinical Medicine, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.